Marlene L Durand
Overview
Explore the profile of Marlene L Durand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barshak M, Durand M, Gupta A, Mohareb A, Dohlman T, Papaliodis G
Clin Infect Dis
. 2024 Nov;
79(5):1125-1126.
PMID: 39571608
No abstract available.
2.
Barshak M, Durand M, Gupta A, Mohareb A, Dohlman T, Papaliodis G
Clin Infect Dis
. 2024 Nov;
79(5):e48-e64.
PMID: 39571607
No abstract available.
3.
Mohareb A, Barshak M, Papaliodis G, Sobrin L, Durand M
Clin Infect Dis
. 2024 Jul;
PMID: 38953389
Background: Screening for syphilis increasingly relies on positive treponemal rather than nontreponemal tests (rapid plasma reagin [RPR]). We compared ocular syphilis in patients with nonreactive versus positive RPR. Methods: We...
4.
Durand M, Barshak M, Sobrin L
N Engl J Med
. 2023 Dec;
389(25):2363-2375.
PMID: 38118024
No abstract available.
5.
Cummings O, Durand M, Barshak M, Bispo P
Ocul Immunol Inflamm
. 2023 Oct;
32(8):1580-1584.
PMID: 37797201
Introduction: Ocular syphilis is a rare but potentially sight-threatening manifestation of infection with the spirochete subspecies . Molecular strain typing of clinical specimens obtained from patients with syphilis can provide...
6.
Chang C, McCoul E, Briggs S, Guardiani E, Durand M, Hadlock T, et al.
Otolaryngol Head Neck Surg
. 2021 Dec;
167(5):803-820.
PMID: 34874793
Objective: To offer pragmatic, evidence-informed advice on administering corticosteroids in otolaryngology during the coronavirus disease 2019 (COVID-19) pandemic, considering therapeutic efficacy, potential adverse effects, susceptibility to COVID-19, and potential effects...
7.
Durand M, Barshak M, Chodosh J
JAMA
. 2021 Oct;
326(13):1319-1320.
PMID: 34609465
No abstract available.
8.
Tjoa T, Rathi V, Goyal N, Yarlagadda B, Barshak M, Rich D, et al.
Oral Oncol
. 2021 Sep;
122:105541.
PMID: 34564017
Objectives: Medical postoperative infections (MPIs) are important causes of morbidity following major head and neck free and pedicled flap reconstruction, but the incidence, time of onset, and microbiology are not...
9.
Durand M, Kitt T, Song Y, Marty F
Clin Infect Dis
. 2021 Apr;
73(6):e1380-e1383.
PMID: 33914864
This post hoc analysis of international phase III isavuconazole trials identified 50 patients (90% immunocompromised or diabetic) with invasive fungal sinusitis (88% mucormycetes, Aspergillus) who received isavuconazole as primary (n...
10.
Andre C, Durand M, Buckley T, Cadorette J, Gilmore M, Ciolino J, et al.
Cornea
. 2021 Jan;
40(2):223-227.
PMID: 33395117
Purpose: To investigate a cluster of corneoscleral rim cultures positive for Achromobacter species over a 6-month period at Massachusetts Eye and Ear. Methods: An increased rate of positive corneal donor...